Related Experiment Video

Updated: Jan 8, 2026

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
09:03

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

10.1K

Targeting angiogenesis in cancer therapy: lessons learned and paths forward

Kathrine S Rallis1

  • 1Barts Cancer Institute, Queen Mary University of London, London, UK.

Expert Review of Anticancer Therapy
|December 24, 2025
PubMed
Abstract

Insights

Anti-angiogenic therapies, which inhibit new blood vessel formation, are crucial in cancer treatment. Future research should focus on personalized medicine and combination strategies to improve efficacy and overcome resistance.

Area of Science:

  • Oncology
  • Vascular Biology

Background:

  • Angiogenesis, the formation of new blood vessels, is vital for tumor growth and metastasis.
  • Inhibiting angiogenesis is a key strategy in modern anticancer therapy.

Purpose of the Study:

  • To review the biological processes of angiogenesis.
  • To explore the clinical development and outcomes of anti-angiogenic therapies in various cancers.

Main Methods:

  • Comprehensive literature search on approved and emerging anti-angiogenic agents.
  • Analysis of combination strategies, clinical outcomes, limitations, and recent advances.

Main Results:

  • Anti-angiogenic therapies have shown significant impact but face challenges like variable efficacy, drug resistance, and toxicity.
  • Recent advances include biomarker discovery, immunotherapy combinations, and novel targets.

Conclusions:

  • Anti-angiogenic agents have transformed cancer therapy but require further optimization.
  • Future directions emphasize personalized medicine with predictive biomarkers and rational combination therapies to enhance efficacy and combat resistance.
Keywords:
AngiogenesisVEGFblood vesselscancertherapy

More Related Videos

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay09:03

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay

Published on: June 30, 2023

1.6K
Author Spotlight: Investigating Angiogenesis Through Challenges and Innovations in Assay Development09:16

Author Spotlight: Investigating Angiogenesis Through Challenges and Innovations in Assay Development

Published on: May 31, 2024

2.0K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.6K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K